Zileuton Therapy is a pharmacological intervention that selectively inhibits 5-lipoxygenase, thereby suppressing leukotriene synthesis, and is specifically indicated for the management of asthma as a small-molecule, mechanism-targeted anti-inflammatory treatment.
162
Publications
8.1K
Citations
792
Authors
258
Institutions
Publications per year
2017–2026
29
Parents
Publications
162
1–5 of 162
Authors
792
- LM
15
h-index
- WM
11
h-index
- JH
10
h-index
- GR
10
h-index
- RA
8
h-index
1–5 of 792
Institutions
258
Abbott Fund
Chicago, United States
14 h-index
71 publications
1.9K citations
Abbott (United Kingdom)
Maidenhead, United Kingdom
12 h-index
58 publications
1.5K citations
Abbott (United States)
Chicago, United States
11 h-index
51 publications
1.6K citations
Immunosciences Lab (United States)
Los Angeles, United States
9 h-index
39 publications
5.9K citations
Brigham and Women's Hospital
Boston, United States
9 h-index
29 publications
3.9K citations
Union Hospital
Fuzhou, China
5 h-index
28 publications
1.2K citations
University of Colorado Denver
Denver, United States
4 h-index
15 publications
479 citations
Karolinska Institutet
Stockholm, Sweden
4 h-index
33 publications
5.4K citations
1–8 of 258
Venues
- Clinical Pharmacokinetics
11 publications · 286 citations
10
h-index
- PubMed
Repository · 10 publications · 549 citations
10
h-index
- American Journal of Respiratory and Critical Care Medicine
AJRCCM · 6 publications · 785 citations
6
h-index
- Journal of Pharmacology and Experimental Therapeutics
4 publications · 80 citations
4
h-index
- Annals of Allergy Asthma & Immunology
ACAAI · 3 publications · 162 citations
3
h-index
1–5